CooperCompanies reported a 6% increase in revenue year-over-year, reaching $1,060.3 million.
CooperVision revenue rose by 6% to $718.4 million, while CooperSurgical revenue increased by 4% to $341.9 million.
GAAP diluted earnings per share (EPS) were $0.49, reflecting a 6% decrease from the previous year's third quarter.
Non-GAAP diluted EPS reached $1.10, marking a 15% increase from the prior year.
Revenue Growth
Revenue increased by 6% year-over-year, demonstrating steady financial performance.
Earnings Comparison
GAAP EPS decreased by 6%, contrasting with a 15% rise in Non-GAAP EPS.
Operational Excellence
The company emphasized strong margins, double-digit earnings growth, and robust cash flow, showcasing operational efficiency.
- CooperCompanies exhibited resilient financial performance with positive revenue and EPS trends.
- Operational excellence and strategic positioning point towards sustainable growth and value creation for shareholders.
Despite slightly lower revenues, CooperCompanies' operational strength and growth outlook remain positive, driving confidence in its long-term performance and shareholder value creation.